- Home
- FBIOP vs OBA Comparison
FBIOP vs OBA Comparison
Compare FBIOP & OBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- OBA
- Stock Information
- Founded
- FBIOP N/A
- OBA 2024
- Country
- FBIOP United States
- OBA Canada
- Employees
- FBIOP 101
- OBA N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- OBA
- Sector
- FBIOP Health Care
- OBA
- Exchange
- FBIOP Nasdaq
- OBA Nasdaq
- Market Cap
- FBIOP N/A
- OBA N/A
- IPO Year
- FBIOP N/A
- OBA 2025
- Fundamental
- Price
- FBIOP $7.75
- OBA $9.94
- Analyst Decision
- FBIOP
- OBA
- Analyst Count
- FBIOP 0
- OBA 0
- Target Price
- FBIOP N/A
- OBA N/A
- AVG Volume (30 Days)
- FBIOP N/A
- OBA 14.3K
- Earning Date
- FBIOP N/A
- OBA 01-01-0001
- Dividend Yield
- FBIOP N/A
- OBA N/A
- EPS Growth
- FBIOP N/A
- OBA N/A
- EPS
- FBIOP N/A
- OBA N/A
- Revenue
- FBIOP N/A
- OBA N/A
- Revenue This Year
- FBIOP N/A
- OBA N/A
- Revenue Next Year
- FBIOP N/A
- OBA N/A
- P/E Ratio
- FBIOP N/A
- OBA N/A
- Revenue Growth
- FBIOP N/A
- OBA N/A
- 52 Week Low
- FBIOP N/A
- OBA $10.00
- 52 Week High
- FBIOP N/A
- OBA $10.06
- Technical
- Relative Strength Index (RSI)
- FBIOP 55.31
- OBA N/A
- Support Level
- FBIOP $7.25
- OBA N/A
- Resistance Level
- FBIOP $7.89
- OBA N/A
- Average True Range (ATR)
- FBIOP 0.36
- OBA 0.00
- MACD
- FBIOP 0.06
- OBA 0.00
- Stochastic Oscillator
- FBIOP 76.67
- OBA 0.00
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.